SNS Financial Group LLC trimmed its holdings in CME Group Inc (NASDAQ:CME) by 27.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,791 shares of the financial services provider’s stock after selling 6,596 shares during the quarter. CME Group comprises 0.7% of SNS Financial Group LLC’s portfolio, making the stock its 28th largest holding. SNS Financial Group LLC’s holdings in CME Group were worth $3,453,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Guinness Asset Management Ltd boosted its stake in CME Group by 20.1% during the 2nd quarter. Guinness Asset Management Ltd now owns 126,890 shares of the financial services provider’s stock valued at $24,631,000 after purchasing an additional 21,280 shares in the last quarter. Guinness Atkinson Asset Management Inc boosted its stake in shares of CME Group by 7.9% during the 2nd quarter. Guinness Atkinson Asset Management Inc now owns 1,640 shares of the financial services provider’s stock worth $318,000 after acquiring an additional 120 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its stake in shares of CME Group by 11.6% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 36,315 shares of the financial services provider’s stock worth $7,049,000 after acquiring an additional 3,789 shares in the last quarter. Swarthmore Group Inc. boosted its stake in shares of CME Group by 930.6% during the 2nd quarter. Swarthmore Group Inc. now owns 37,100 shares of the financial services provider’s stock worth $7,201,000 after acquiring an additional 33,500 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. boosted its stake in shares of CME Group by 41.1% during the 2nd quarter. Shine Investment Advisory Services Inc. now owns 625 shares of the financial services provider’s stock worth $121,000 after acquiring an additional 182 shares in the last quarter. 84.58% of the stock is owned by institutional investors and hedge funds.
Shares of NASDAQ:CME traded up $0.28 during midday trading on Wednesday, hitting $208.66. 734,534 shares of the stock were exchanged, compared to its average volume of 1,258,474. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a 52-week low of $161.05 and a 52-week high of $209.15. The stock’s fifty day moving average is $201.27. The company has a market cap of $74.64 billion, a P/E ratio of 30.60, a PEG ratio of 4.58 and a beta of 0.23.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. CME Group’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period last year, the company earned $1.74 earnings per share. On average, analysts anticipate that CME Group Inc will post 6.66 EPS for the current fiscal year.
CME has been the subject of several research reports. BidaskClub lowered CME Group from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 11th. ValuEngine upgraded CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective for the company. in a report on Monday, May 27th. Citigroup set a $202.00 price objective on CME Group and gave the stock a “buy” rating in a report on Thursday, May 2nd. Finally, Rosenblatt Securities lowered CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $192.14.
In other CME Group news, insider Kathleen M. Cronin sold 4,960 shares of the stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $186.69, for a total transaction of $925,982.40. Following the transaction, the insider now directly owns 49,337 shares of the company’s stock, valued at $9,210,724.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Howard J. Siegel sold 5,000 shares of the stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $205.00, for a total transaction of $1,025,000.00. Following the transaction, the director now directly owns 80,382 shares in the company, valued at $16,478,310. The disclosure for this sale can be found here. Insiders have sold 78,873 shares of company stock worth $15,707,799 over the last three months. Company insiders own 1.20% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
See Also: 12b-1 Fees
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.